The protein assay market was valued at $2,377.93 million in 2022 and is estimated to reach $4,449.02 million by 2032, exhibiting a CAGR of 6.5% from 2023 to 2032.
The purpose of protein assay is to determine the amount or concentration of a specific protein or an array of different proteins in a sample. Isolating and detecting protein is used for many clinical and research processes. This can be a primary step before further manipulation in a research and development process, an initial capture of protein before structural analysis, or it can be a final detection step in a clinical laboratory as part of a disease diagnosis.
The determination of protein concentrations provides information about the necessity of corresponding intermediate steps. Protein quantitation could either be required for the total protein content of a sample, or for purified subsets thereof, such as affinity column fractions. There are various methods for protein assays such as dye binding protein assays (Bradford), protein assays based on copper ions (Lowry), or a novel test strip and spot application assay.
Major factors that drive the growth of the global protein assays market include rise in prevalence of chronic disease, upsurge in demand for personalized medicine, and critical role of protein assay method in drug discovery and development. Furthermore, increase in R&D investment in pharmaceutical & biotechnology industries for the development of technologically advanced protein assay kits and reagents and instruments and increase in the number of research activities in the field of proteomics are the major factors that increase the demand for protein assays tests kits and instruments and hence propel the growth of the market. In addition, increase in number of key market players and strategies they adopt for the development of technologically advanced protein assays products are the major factors that boost the growth of the protein assays market. For instance, in May 2023, 10x Genomics, Inc. a leader in single cell and spatial biology, announced the commercial availability of a new Visium CytAssist gene and protein expression product to expand the breadth of the Visium CytAssist spatial analysis capabilities. Visium CytAssist gene and protein expression enables researchers to simultaneously produce highly multiplexed protein and whole transcriptome RNA data mapped together from the same formalin-fixed, paraffin-embedded (FFPE) tissue section at high spatial resolution.
However, the lack of skilled workers and prohibitive cost associated with protein assay restrain the growth of the protein assays market. On the contrary, surge in demand for personalized medicine and expansion in the use of drug proteins are expected to provide lucrative opportunities for the growth of the protein assays market during the forecast period.
The protein assays market is segmented into product type, technology, application, end user, and region. Based on product type, the market is bifurcated into kits & reagents and instruments and accessories. Based on technology, it is divided into absorbance-based protein assay, colorimetric based protein assay and fluorescence-based protein assays. Based on application, it is classified into drug discovery and development and disease diagnosis. Based on end user, it is divided into pharmaceutical and biotechnology companies, clinical laboratories, and others. On the basis of region, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
The major players profiled in the report are Sartorius AG, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Perkin Elmer Inc., Meril Life Sciences Pvt. Ltd., Abcam PLC, Cell Signaling Technology, Merck KGaA, Bio-Rad Laboratories Inc, and Bio-Techne. The key players such as Sartorius AG and Abcam PLC have adopted product launch, acquisition, and partnership as major developmental strategies to improve the product portfolio.
The purpose of protein assay is to determine the amount or concentration of a specific protein or an array of different proteins in a sample. Isolating and detecting protein is used for many clinical and research processes. This can be a primary step before further manipulation in a research and development process, an initial capture of protein before structural analysis, or it can be a final detection step in a clinical laboratory as part of a disease diagnosis.
The determination of protein concentrations provides information about the necessity of corresponding intermediate steps. Protein quantitation could either be required for the total protein content of a sample, or for purified subsets thereof, such as affinity column fractions. There are various methods for protein assays such as dye binding protein assays (Bradford), protein assays based on copper ions (Lowry), or a novel test strip and spot application assay.
Major factors that drive the growth of the global protein assays market include rise in prevalence of chronic disease, upsurge in demand for personalized medicine, and critical role of protein assay method in drug discovery and development. Furthermore, increase in R&D investment in pharmaceutical & biotechnology industries for the development of technologically advanced protein assay kits and reagents and instruments and increase in the number of research activities in the field of proteomics are the major factors that increase the demand for protein assays tests kits and instruments and hence propel the growth of the market. In addition, increase in number of key market players and strategies they adopt for the development of technologically advanced protein assays products are the major factors that boost the growth of the protein assays market. For instance, in May 2023, 10x Genomics, Inc. a leader in single cell and spatial biology, announced the commercial availability of a new Visium CytAssist gene and protein expression product to expand the breadth of the Visium CytAssist spatial analysis capabilities. Visium CytAssist gene and protein expression enables researchers to simultaneously produce highly multiplexed protein and whole transcriptome RNA data mapped together from the same formalin-fixed, paraffin-embedded (FFPE) tissue section at high spatial resolution.
However, the lack of skilled workers and prohibitive cost associated with protein assay restrain the growth of the protein assays market. On the contrary, surge in demand for personalized medicine and expansion in the use of drug proteins are expected to provide lucrative opportunities for the growth of the protein assays market during the forecast period.
The protein assays market is segmented into product type, technology, application, end user, and region. Based on product type, the market is bifurcated into kits & reagents and instruments and accessories. Based on technology, it is divided into absorbance-based protein assay, colorimetric based protein assay and fluorescence-based protein assays. Based on application, it is classified into drug discovery and development and disease diagnosis. Based on end user, it is divided into pharmaceutical and biotechnology companies, clinical laboratories, and others. On the basis of region, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
The major players profiled in the report are Sartorius AG, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Perkin Elmer Inc., Meril Life Sciences Pvt. Ltd., Abcam PLC, Cell Signaling Technology, Merck KGaA, Bio-Rad Laboratories Inc, and Bio-Techne. The key players such as Sartorius AG and Abcam PLC have adopted product launch, acquisition, and partnership as major developmental strategies to improve the product portfolio.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the protein assays market analysis from 2022 to 2032 to identify the prevailing protein assays market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the protein assays market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global protein assays market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Market share analysis of players by products/segments
- New Product Development/Product Matrix of Key Players
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Average Selling Price Analysis/Price Point Analysis
- Expanded list for Company Profiles
- Historic market data
- SWOT Analysis
Key Market Segments
By Application
- Drug Discovery and Development
- Disease Diagnosis
By Product Type
- Kits and Reagents
- Instruments and Accessories
By Technology
- Absorbance Based Protein Assays
- Colorimetric based protein assay
- Fluorescence-Based Protein Assays
By End User
- Pharmaceutical and biotechnology companies
- Clinical Laboratories
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Agilent Technologies, Inc.
- Perkin Elmer Inc
- Abcam Plc
- Meril Life Sciences Pvt. Ltd.
- Cell Signaling Technology
- Sartorius AG
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- Bio-Techne
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: PROTEIN ASSAYS MARKET, BY PRODUCT TYPE
CHAPTER 5: PROTEIN ASSAYS MARKET, BY TECHNOLOGY
CHAPTER 6: PROTEIN ASSAYS MARKET, BY APPLICATION
CHAPTER 7: PROTEIN ASSAYS MARKET, BY END USER
CHAPTER 8: PROTEIN ASSAYS MARKET, BY REGION
CHAPTER 9: COMPETITIVE LANDSCAPE
CHAPTER 10: COMPANY PROFILES
List of Tables
List of Figures
Companies Mentioned
- Agilent Technologies, Inc.
- Perkin Elmer Inc
- Abcam Plc
- Meril Life Sciences Pvt. Ltd.
- Cell Signaling Technology
- Sartorius AG
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- Bio-Techne
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
